| Literature DB >> 32360173 |
Michelle M Graham1, Lyall Higginson2, Peter G Brindley3, Rakesh Jetly4.
Abstract
Entities:
Mesh:
Year: 2020 PMID: 32360173 PMCID: PMC7161513 DOI: 10.1016/j.cjca.2020.04.012
Source DB: PubMed Journal: Can J Cardiol ISSN: 0828-282X Impact factor: 5.223
COVID-19 topics covered by the CCS Rapid Response Team.
| Date | Topic |
|---|---|
| March 15, 2020 | CCS’s response to the COVID-19 pandemic |
| March 15, 2020 | COVID-19 and use of ACEi/ARB/ARNi medications for heart failure or hypertension |
| March 16, 2020 | COVID-19 and cardiac device patients: a message from the Canadian Heart Rhythm Society |
| March 17, 2020 | Guidance on ambulatory management and diagnostic testing during the COVID-19 crisis |
| March 17, 2020 | Joint letter to the Deputy Ministers of Health and Public Safety offering expert guidance on a coordinated strategy regarding the use of ECMO during the COVID-19 pandemic |
| March 19, 2020 | Guidance on hospital-based care and cardiac procedures during the COVID-19 crisis |
| March 20, 2020 | Updated. COVID-19 and concerns regarding use of cardiovascular medications, including ACEi/ARB/ARNi, low-dose ASA and nonsteroidal anti-inflammatory drugs (NSAIDS) |
| March 22, 2020 | COVID-19 and cardiovascular disease: what the cardiac healthcare provider should know |
| March 25, 2020 | Guidance on community-based care of the cardiovascular patient during the COVID-19 pandemic |
| March 30, 2020 | Reducing in-hospital spread and the optimal use of resources for the care of hospitalized cardiovascular patients during the COVID-19 pandemic |
| April 1, 2020 | Is it COVID-19 or is it heart failure: management of ambulatory heart failure patients |
| April 7, 2020 | Management of referral, triage, waitlist and reassessment of cardiac patients during the COVID-19 pandemic |
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin receptor - neprilysin inhibitor; ASA, acetylsalicylic acid; CCS, Canadian Cardiovascular Society; ECMO, extracorporeal membrane oxygenation.